Bob Djavan

Canadian Journal of Urology, Vol.18, No.1, pp. 5536-5536, 2011

Abstract This article has no abstract. More >

Jacobo Arce, Josep M. Gaya, Jorge Huguet, Oscar Rodriguez, Joan Palou, Humberto Villavicencio

Canadian Journal of Urology, Vol.18, No.1, pp. 5529-5536, 2011

Abstract Objectives: To determine which patients may benefit from prostate-sparing surgery and which factors are predictive of invasive prostatic involvement.
Materials and methods: A total of 717 men underwent radical cystoprostatectomy (RC) for bladder transitional cell carcinoma (TCC) between 1978 and 2002. Analysis of prostatic urethral involvement by transitional cell carcinoma (pTCC) and of invasive prostatic involvement by TCC was performed according to recurrence, presence of carcinoma in situ (CIS) and multifocality, previous intravesical chemotherapy, grade, stage and location of bladder tumor, presence of CIS in precystectomy transurethral resection (TUR) and indication for RC.
Results: pTCC was present in… More >

Paul K. Hegarty

Canadian Journal of Urology, Vol.18, No.1, pp. 5528-5528, 2011

Abstract This article has no abstract. More >

Matthew McIntyre¹, Avi Weiss², Amy Wahlquist¹, Thomas Keane¹, Harry Clarke¹, Stephen Savage¹

Canadian Journal of Urology, Vol.18, No.1, pp. 5524-5528, 2011

Abstract Introduction: Penile cancer is rare, often presenting in later stages. We sought to determine if factors potentially related to access to care were associated with worse outcomes.
Methods: We performed a retrospective review of all patients with the diagnosis of penile cancer over a 14 year period at the only tertiary referral center in the state. We collected data on multiple factors potentially associated with access to care.
Results: Fifty-fve patients with penile cancer were identifed. The average age was 57 years. Of the 55 patients, 23 patients (42%) had private insurance carriers, 16 (29%) had Medicare/Medicaid, 13… More >

Francesca Vita¹, Salvatore Siracusano², Rita Abbate¹, Stefano Ciciliato², Violetta Borelli¹, Maria Rosa Soranzo¹, Giuliano Zabucchi¹

Canadian Journal of Urology, Vol.18, No.1, pp. 5517-5523, 2011

Abstract Introduction: Bacillus Calmette-Guérin (BCG) is used to treat high risk superficial bladder cancer, but its anti-tumor effect remains incompletely defined. Recently a role for polymophonuclear (PMN) neutrophils has been suggested. To investigate the role of granulocytes, we monitored the activation state of these cells in the urine of BCG-treated patients.
Materials and methods: Ten patients with stage T1, grade 3 (T1G3) transitional cell carcinoma received an 8 week course of BCG after undergoing transurethral resection of the bladder. Cytological and enzymatic analyses of urine samples collected before and 2 hours after the physiological expulsion of BCG were… More >

Arnaldo Mendez, Mohamad Sawan

Canadian Journal of Urology, Vol.18, No.1, pp. 5504-5516, 2011

Abstract Chronic monitoring of bladder volume can improve the clinical diagnosis and the choice of therapeutic approach for patients suffering from urinary dysfunction. It can also be employed to notify patients or healthcare personnel when the bladder should be emptied. An early warning can be triggered either when functional bladder capacity is reached or when an abnormally high postvoiding residual volume remains in the bladder after an unfinished voiding. Currently, neuroprosthetic implants are used in the treatment of refractory patients with overactive bladder, with urgency-frequency or with voiding complications. These implants can further enhance their performance, More >

Guy Vallancien

Canadian Journal of Urology, Vol.18, No.1, pp. 5501-5503, 2011

Abstract This article has no abstract. More >

Leonard G. Gomella

Canadian Journal of Urology, Vol.18, No.1, pp. 5500-5500, 2011

Abstract This article has no abstract. More >

John Lazarus, Lisa Kaestner

Canadian Journal of Urology, Vol.18, No.2, pp. 5663-5665, 2011

Abstract A 48-year-old HIV positive woman presented with urgency, frequency, recurrent cystitis and episodic macroscopic hematuria. Cystoscopy revealed papillary lesions involving most of the bladder. Histology of bladder biopsies revealed human papilloma virus (HPV) associated condyloma acuminata. We discuss the treatment of this rare lesion and review the literature. More >

Jay Heintz, Barbara Kahn, Andrew Kramer

Canadian Journal of Urology, Vol.18, No.2, pp. 5660-5662, 2011

Abstract Introduction: To report an unusual presentation of metastatic prostate cancer to the orbit in an immunosuppressed patient, who received a novel palliative treatment regimen.
Materials and methods: A 56 year old HIV+ man presented with proptosis and unilateral blindness. The diagnosis, work up, and treatment are outlined.
Results: Metastatic prostate cancer to the orbit is diagnosed, and the treatment with IMRT and hormone ablation is explored.
Conclusion: We outline the literature and current thinking surrounding prostate cancer metastases to the orbit. HIV+ patients currently enjoy longer life expectancies, with the caveat that their immunosuppressed status may lead to more More >